CVS Health Corp is seeking to buy Signify Health Inc as it looks to expand in-home health services, the Wall Street Journal reported on Sunday, citing sources.
Signify Health is working with bankers to explore strategic alternatives, including a sale, the Journal reported last week.
Initial bids are due this coming week, and CVS is planning to enter one, the report said. Signify has a market cap of around $4.66 billion based on its stock closing price on Friday, according to Refinitiv calculations.
CVS, which runs drugstores and provides health insurance, is among the companies seeking to submit initial bids this week, the Wall Street Journal wrote Sunday. The Journal reported last week that Signify, which had a stock-market capitalization of $4.66 billion as of Friday, was exploring strategic alternatives including a possible sale.
Through its software and services, Signify aims to help clients — payers like health plans, government programs and employers — shift to value-based payment plans. These arrangements are intended to improve care and reduce spending by treating patients in lower-cost settings and linking providers’ payments to patient outcomes. An acquisition may align with CVS Chief Executive Officer Karen Lynch’s move toward more interaction with patients, including primary care locations in its chain of drugstores.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Massachusetts AG Sues Insulin Makers and PBMs Over Alleged Price-Fixing Scheme
Jan 14, 2025 by
CPI
Apple and Amazon Avoid Mass Lawsuit in UK Over Alleged Collusion
Jan 14, 2025 by
CPI
Top Agent Network Drops Antitrust Suit Against National Association of Realtors
Jan 14, 2025 by
CPI
Weil, Gotshal & Manges Strengthens Antitrust Practice with New Partner
Jan 14, 2025 by
CPI
Russian Court Imposes Hefty Fine on Google for Non-Compliance with Content Removal Orders
Jan 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand